Screener/Healthcare/Biotechnology

PTGX

Protagonist Therapeutics, Inc.NASDAQ
$100.33+1.79 (+1.82%)
Mid CapHealthcareHigh Beta
$39.60
$105.69
$97.16
$100.98
EPS (TTM)$-2.06
P/E Ratio—
Dividend Yield—
Market Cap$6.49B
Volume374K
Prev Close$98.54
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$7.4M-$44.4M$-0.70—-596.8%
Q3 '25$4.7M-$39.3M$-0.62—-834.9%
Q2 '25$5.5M-$34.8M$-0.55—-627.0%
Q1 '25$28.3M-$11.7M$-0.19—-41.2%
Q3 '24$4.7M-$33.2M$-0.54—-710.4%
Q2 '24$4.2M-$30.6M$-0.50—-734.7%
Q1 '24$255.0M$207.3M$3.26—81.3%
Q4 '23$60.0M$27.3M$0.52—45.6%
Get Your Daily Market Recap